Updates on Pediatric Hepatoblastoma
- By Consolato M. Sergi1
-
View Affiliations Hide AffiliationsAffiliations: 1 Division of Anatomic Pathology, Children`s Hospital of Eastern Ontario, University of Ottawa, ON, Canada | Department of Laboratory Medicine and Pathology, Stollery Children’s Hospital, University ofAlberta, Edmonton, AB, Canada
- Source: Common Pediatric Diseases: An Updated Review , pp 437-451
- Publication Date: April 2022
- Language: English
The developing human liver is embryologically central in embryogenesis. It plays a significant role as a hematopoietic and endocrine organ. During the development, hepatocytes change their phenotype. They vary from blueish cells to cells with an eosinophilic nuance and decreased nucleus to cytoplasm ratio. Apart from congenital abnormalities of this organ and inflammatory conditions that can populate medical charts in childhood and youth, the liver's neoplastic transformation in childhood and adolescence is a rare event. In children younger than three years, the liver's most dramatic neoplasm is represented by the occurrence of hepatoblastoma. It is an embryologic tumor. It retains the suffix “blastoma,” similar to neuroblastoma as any other embryologic tumor. Hepatoblastoma originates presumably from the primitive embryo-fetal progenitors. In this chapter, we update our knowledge of this pediatric tumor, specifically the pathology and the treatment
-
From This Site
/content/books/9789815039658.chap13dcterms_subject,pub_keyword-contentType:Journal105